Biopharma Leaders Talk Radical Steps, Regulatory Reform, Open AI To Spur India R&D

L-R: Dr. Ajit Rangnekar, Dr. Harish Iyer, Dr. Yamuna Krishnan, Dr. Radha Rangarajan, Mr Satish Reddy, Professor Jack W. Szostak, Dr. Guru N. Reddy, Dr. Shridhar Narayanan, Dr. Ravindranathan, Dr. Murali Ramachandra, Dr. Srinivas Oruganti, Anju Ghangurde, Tejasvi Poorna Chandra and Dinesh Reddy Musukula. • Source: Dr Reddy's Laboratories
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip